Treatment of infants with congenital nasolacrimal duct obstruction
10.3980/j.issn.1672-5123.2014.07.51
- VernacularTitle:婴幼儿先天性鼻泪管阻塞的治疗探讨
- Author:
Zhuo, CHEN
;
Hai-Jia, XU
;
Yi-Ping, XIAN
;
Bi-Hua, XIE
;
Bing-Hua, TANG
- Publication Type:Journal Article
- Keywords:
congenital nasolacrimal duct obstruction;
lacrimal nasolacrimal duct massage;
lacrimal pressure washing;
nasolacrimal duct probing surgery
- From:
International Eye Science
2014;(7):1344-1347
- CountryChina
- Language:Chinese
-
Abstract:
AlM: To explore the different ages of congenital nasolacrimal duct obstruction in infants, take different treatment methods at different times.
METHODS:The 87 cases of 102 children were divided into three different age groups: the first group of 25d-3mo of age 21 cases 26 eyes; The second group >3mo-7mo 31 cases 36 eyes;The third group >7-24mo of age 35 cases 40 eyes. For the first group of infants, the implementation of the lacrimal sac nasolacrimal duct massage + eye drops; for the second group of infants, carry lacrimal pressure washing treatment; for the third group of infants, the implementation of the nasolacrimal duct probing treatment.
RESULTS: The first group of children through the nasolacrimal duct sac massage + drops tobramycin eye drops treatment unobstructed 12, the cure rate was 46. 2%;The second group of children through pressurized irrigation treatment lacrimal patency by 33, the cure rate was 91. 7%; The third group of children through the nasolacrimal duct probing unobstructed 36 treatment, the cure rate was 90. 0%. The second and third group were better than the first group (χ2=15. 71, P<0. 01;χ2=15. 27, P<0. 01);the treatment effect of the second and third groups was no significant difference (χ2=0. 02, P>0. 05).
CONCLUSlON:lnfants with congenital nasolacrimal duct obstruction should distinguish between ages, taking different treatments, in order to obtain a better therapeutic effect, and lacrimal pressure washing is the preferred way of treating infants with congenital nasolacrimal duct obstruction.